Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-19

FDA Approved: ALVIMOPAN — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved ALVIMOPAN (alvimopan) from Actavis Pharma, Inc. via an original ANDA, granting marketing authorization for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alvimopan (alvimopan)

Snippet

ORIG AP for ALVIMOPAN (ALVIMOPAN)